Articles citing this paper
Cost-effectiveness of a bivalent human papillomavirus vaccination program in Japan
Luke B. Connelly A C and Ha N. D. Le B
+ Author Affiliations
- Author Affiliations
A The University of Queensland, Faculty of Health and Behavioural Sciences, Level 7, Oral Health Building, Herston, Qld 4006, Australia.
B Deakin Health Economics, Population Health SRC, Deakin University, Level 3, Building BC, 221 Burwood Highway, Burwood, Vic. 3125, Australia.
C Corresponding author. Email: l.connelly@uq.edu.au
Sexual Health 12(6) 520-531 https://doi.org/10.1071/SH14241
Submitted: 18 December 2014 Accepted: 17 June 2015 Published: 28 September 2015
7 articles found in Crossref database.
Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature
Silas Olugbenga Akindele,
Achenbach Chad J.,
Murphy Robert Leo,
Hou Lifang,
Sagay Solomon Atiene,
Banwat Edmund,
Adoga Adeyi A.,
Musa Jonah, French Dustin Douglas
Expert Review of Vaccines. 2018 17(1). p.91
Alternative New Mono-scaled Quantitative Benefit–Risk Assessment of Human Papillomavirus Vaccine in Japan
Matsumoto Tomoko,
Matsumaru Naoki,
Scuffham Paul,
Neels Pieter, Tsukamoto Katsura
Therapeutic Innovation & Regulatory Science. 2021 55(1). p.48
Stopping the HPV vaccine crisis in Japan: Quantifying the benefits and risks of HPV vaccination in quality-adjusted life-years for appropriate decision-making
Kitano Taito
Journal of Infection and Chemotherapy. 2020 26(3). p.225
The cost-effectiveness of bivalent, quadrivalent, and nine-valent HPV vaccination in Asia: a systematic review
Zhu Ke,
Tian Yuke,
Dong Xiaomei,
Akinwunmi Babatunde O.,
Zhang Casper J. P.,
Huang Jian, Ming Wai-kit
Archives of Gynecology and Obstetrics. 2022 306(1). p.173
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
Doggen Kris,
van Hoek Albert Jan, Luyten Jeroen
PharmacoEconomics. 2023 41(5). p.481
Human Papillomavirus (2020)
How to recover lost vaccine acceptance? A multi-center survey on HPV vaccine acceptance in Japan
Mizumachi Kuniyoshi,
Aoki Hirosato,
Kitano Taito,
Onishi Tomoko,
Takeyama Masahiro, Shima Midori
Journal of Infection and Chemotherapy. 2021 27(3). p.445
